Viewing Study NCT00145158


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2026-05-15 @ 3:09 PM
Study NCT ID: NCT00145158
Status: TERMINATED
Last Update Posted: 2022-10-10
First Post: 2005-09-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma
Sponsor: Ludwig Institute for Cancer Research
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: LUD2003-007
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators